| Product Information |
|
| Registration Number |
DR-XY44203
|
| Generic Name |
Fluticasone Furoate + Vilanterol (as trifenatate)
|
| Brand Name |
Relvar Ellipta
|
| Dosage Strength |
200 mcg/25 mcg (equivalent to 184 mcg/22 mcg
delivered dose)
|
| Dosage Form |
Dry Powder For Inhalation
|
| Classification |
Prescription Drug (Rx)
|
| Pharmacologic Category |
-
|
| Packaging |
Sealed foil laminate tray containing a light grey body
with pale blue mouthpiece cover and dose counter inhaler x 30 doses and a dessicant packet (Box of l's)
|
| Manufacturer |
Glaxo Operations UK Ltd.
|
| Country of Origin |
United Kingdom
|
| Trader |
N/A
|
| Importer |
GlaxoSmithKline Philippines, Inc.
|
| Distributor |
N/A
|
| Application Type |
Initial [from Monitored Release] Reconstruction
|
| Issuance Date |
06 June 2022
|
| Expiry Date |
13 February 2025
|